Olanzapina Benel (Olanzapine)

Olanzapine, the active ingredient in Olanzapina Benel, is an atypical antipsychotic presented as a tablet for oral use. It is primarily used to manage symptoms of schizophrenia and bipolar disorder in adults.

GNH USA supplies Olanzapina Benel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olanzapine is indicated for several psychiatric conditions that involve dopamine and serotonin dysregulation. - Schizophrenia: helps reduce hallucinations, delusions and thought disorder. - Bipolar I disorder (manic episodes): aids in controlling mood elevation and agitation. - Bipolar I disorder (maintenance): supports long‑term mood stability. - Major depressive disorder with psychotic features: augments antidepressant therapy to alleviate psychotic symptoms. - Schizoaffective disorder: mitigates both psychotic and mood components.

Olanzapine may cause a range of adverse reactions, from mild to potentially life‑threatening.

Common Side Effects: - Weight gain: increased appetite and caloric intake. - Sedation: drowsiness or feeling of being slowed down. - Dry mouth: reduced salivation. - Constipation: decreased bowel motility. - Elevated triglycerides: rise in blood lipid levels. - Orthostatic hypotension: light‑headedness on standing.

Serious or Rare Side Effects: - Neuroleptic malignant syndrome: high fever, muscle rigidity, autonomic instability. - Tardive dyskinesia: involuntary, repetitive movements, often of the face. - Hyperglycaemia/diabetes mellitus: significant rise in blood glucose. - Seizures: convulsive episodes, especially in predisposed individuals. - Agranulocytosis: dangerously low white‑blood cell count. - Severe allergic reactions: anaphylaxis, angio‑edema.

Precautions: - Monitor metabolic parameters: regularly check weight, fasting glucose and lipid profile. - Assess for movement disorders: watch for early signs of tardive dyskinesia. - Evaluate cardiovascular status: screen for orthostatic hypotension and ECG changes. - Use caution in patients with hepatic or renal impairment: dose adjustments may be needed. - Avoid abrupt discontinuation: taper gradually to reduce withdrawal effects. - Store at ambient temperature: keep in original packaging, protect from moisture.

Interactions: Major Interactions (Avoid): - CNS depressants: may increase sedation and respiratory depression. - Strong CYP1A2 inhibitors: elevate olanzapine plasma concentrations. - Anticholinergic drugs: additive dry‑mouth and constipation effects. - QT‑prolonging agents: increase risk of cardiac arrhythmias. - Alcohol: enhances central nervous system depression.

Moderate Interactions (Monitor Closely): - Smoking: induces CYP1A2, potentially lowering olanzapine levels. - Carbamazepine: may reduce olanzapine exposure. - Fluoxetine/sertraline: can modestly increase olanzapine concentrations. - Antihypertensive agents: may potentiate hypotensive effects. - Lithium: combined use may increase risk of neurotoxicity.

Metatitle: Olanzapina Benel Tablet (Olanzapine) | GNH USA

Metadesc: GNH USA supplies Olanzapina Benel (Olanzapine), a atypical antipsychotic for schizophrenia and bipolar disorder. Request  ...